Mass-produced stem cells on the horizon
22 July 2015 | By Victoria White
Experts at the University of Nottingham have discovered the first fully synthetic substrate with potential to grow billions of stem cells...
List view / Grid view
News
Ablynx expands its immuno-oncology collaboration with MSD
22 July 2015 | By Victoria White
Ablynx has expanded its immuno-oncology collaboration with MSD to address an increased number of immune checkpoint modulator targets...
KalVista raises $33 million to advance development of kallikrein inhibitors
22 July 2015 | By Victoria White
KalVista Pharmaceuticals has raised $33 million in Series B financing to support its research and clinical development programmes...
Roche Diagnostics’ new assay identifies HTLV virus I/II infection
22 July 2015 | By Victoria White
Roche’s Elecsys immunoassay, a diagnostic test to detect antibodies against Human T-lymphotropic virus (HTLV) type I or II, is now available on the market...
Virus-like particle vaccine protects mice from influenza strains
22 July 2015 | By Victoria White
NIAID researchers have devised a way to induce protective immunity in mice against a wide array of influenza viruses using a VLP vaccine...
New ‘TripAdvisor’ site to address use of substandard chemical probes
22 July 2015 | By Victoria White
An international panel of leading scientists has launched a new TripAdvisor-style website aimed at helping researchers choose better-quality chemical probes...
MRC scientists regrow liver from liver stem cells
21 July 2015 | By Victoria White
Medical Research Council (MRC) scientists have repaired a damaged liver in a mouse by transplanting liver stem cells grown in the laboratory...
Researchers discover new peptide toxins in cone snail venom
21 July 2015 | By Victoria White
University of Queensland researchers have discovered thousands of new peptide toxins hidden deep within the venom of just one type of cone snail...
Emergent awarded $19.7 million BARDA contract to develop Ebola monoclonal antibodies
21 July 2015 | By Victoria White
Emergent BioSolutions has been awarded a BARDA contract valued at $19.7 million to develop and manufacture three Ebola monoclonal antibodies...
New insights into biofilm formation could lead to better therapies
21 July 2015 | By
Researchers have now shown that a “messenger molecule” produced by P. aeruginosa encourage bacteria to colonise catheters, forming a biofilm...
Symic Biomedical selects SBCV-030 as vascular clinical candidate
21 July 2015 | By Victoria White
Symic Biomedical has selected SBCV-030 as its vascular clinical candidate. SBCV-030 inhibits the scarring response that occurs when a vessel is injured...
Scientists see iron-containing microglia in Alzheimer’s brains
21 July 2015 | By Victoria White
Examining post-mortem tissue from the brains of people with Alzheimer's disease, researchers identified iron-containing microglia in the hippocampus...
TRV 101 reduces amyloid beta and tau toxic aggregates in Alzheimer’s disease models
20 July 2015 | By Victoria White
TRV 101 has successfully demonstrated significant reduction in both amyloid beta and tau toxic aggregates in mouse models of Alzheimer’s Disease...
Novel treatments emerging for human mitochondrial diseases
20 July 2015 | By
Using existing drugs to restore basic biological processes in human cells, researchers may have devised effective treatments for mitochondrial diseases...
Genetic markers linking risk for type 2 diabetes and Alzheimer’s identified
20 July 2015 | By Victoria White
Certain patients with type 2 diabetes may have specific genetic risk factors that put them at higher risk for developing Alzheimer’s disease...
